The area rate of atheromatous plaque in aorta was less in specimens from both groups of AAS than in those from control I. Pathological changes in intima and media of aorta were milder in specimens from both groups of AAS.
Abstract-Effects of L-ascorbate 2-sulfate (AAS) on lipid metabolism and on patho logical changes of aorta and visceral organs were investigated in cholesterol fed rabbits, with ascorbic acid (AA) and clofibrate (CPIB) as reference compounds. Admin istration of AAS (300 and 150 mg/kg) inhibited an increase in the levels of serum total cholesterol, free cholesterol, triglycerides and phospholipids caused by cholesterol feeding.
A high dose of AAS prevented an increase of liver weight. An increase in the level of liver cholesterol was inhibited by a high dose of AAS. Both doses of AAS effectively prevented an accumulation of cholesterol in the aorta. The area rate of atheromatous plaque in aorta was less in specimens from both groups of AAS than in those from control I. Pathological changes in intima and media of aorta were milder in specimens from both groups of AAS.
Development of pathological changes in arteries of various organs were prevented with both doses of AAS.
The hypocholesterolemic effects of L-ascorbate 2-sulfate (AAS) in mice and rats have been reported in a previous paper (1) in which we suggested that AAS is a prospective hypolipidernic drug having a pronounced effect on lipid metabolism, extremely low toxicity and fewer pharmacological effects on the functions of various organs (2) (3) (4) .
In the present study the effects of AAS on experimental hyperlipidemia and athero sclerosis in rabbits were examined with L-ascorbate (AA) and clofibrate (CPIB) as reference compounds, and it was found that AAS possessed hypolipidemic effects in rabbits as well as in rats, and marked preventive effects on experimental atherosclerosis.
MATERIALS AND METHODS

Materials:
The compounds examined for hypolipidemic effects are sodium L-ascorbate 2-sulfate-3 H2O, sodium L-ascorbate and clofibrate.
Animal treatment: White male rabbits weighing approx. 2.5 kg were divided into 5 groups of nine and each animal was fed daily 100 g of laboratory chow (Nippon Clea, CR-1) supplemented with 1 of cholesterol. In addition to these 5 groups, one group of three animals was fed daily 100 g of laboratory chow (Nippon Clea, CR-1) without cholesterol supplement. The animals were maintained in conditions of 22+1 °C under 55±5% of humidity. During an experimental period of 10 weeks, each group designated as AAS-H, AAS-L, AA and CPIB was given orally the following daily doses of AAS, AA (both as an aqueous solution) or CPIB (as a suspension of 0.5% CMC); AAS-H : 300 nag of AAS/kg, AAS-L: 150 mg of AAS/kg, AA: 150 nag of AA/kg, CPIB: 75 mg of CPIB/kg. Control I (with cholesterol supplement) and control II (without cholesterol supplement) were given saline only.
Analysis of lipids: Blood was withdrown from the ear vein every other week up to the 6th week and every week afterwards, and the serum total cholesterol (5), free cholesterol (6), triglycerides (7) and phospholipids (8) were determined. Lipids in liver and intima of thoracic aorta were extracted by Folch's method (9) , and total cholesterol and triglycerides were measured as described above.
Histopathological examinations: At the end of an experimental period, the animals which were fasted overnight were sacrificed by venesection and autopsied. After a brief gross observation, brain, heart, lung, liver, spleen, kidney, adrenals and aorta were fixed in 101/ formalin. Paraffin slices of these organs were stained with hematoxylin-eosin, elastica
Van Giesen and azan. When necessary, frozen slices of organs were stained with oilred hematoxylin. The entire aorta from the heart to the iliac bifurcation was removed from 5 animals of each group, and stained with Sudan III after being longitudinally cut. Photo graphs of the aorta were cut to be divided into areas with atheromatous lesion and with normal intima, and the area rate (atheromatous to normal) was calculated by weighing both pieces. The aorta from the remaining 4 rabbits from each group were subjected to lipid analysis. Intimal thickening of myocardial arteries was examined in 30 arteries with a diameter of over 40 p in the left venticle and the ratio of numbers of proliferated arteries to 30 arteries examined was calculated.
RESULTS
Body weight
As depicted in Fig. 1 , there was no difference in growth rates between the drug-treated and control groups.
Changes in serum lipid levels
The changes in total cholesterol, free cholesterol, triglyceride and phospholipid levels in rabbits from each group are shown in Table 1 . These levels of the control II changed little during the experimental period.
Total cholesterol:
The serum cholesterol level of the control I was rapidly elevated and reached a maximum (29 fold higher than the value prior to the experiment) at week 9. A marked inhibition in an increase in serum cholesterol level was observed in AAS-H, AAS-L and CPIB groups after week 2, and in AA group after week 8. In comparison to the control I, the levels of AAS-H, AAS-L, CPIB and AA groups were lowered by 57, 30, 24 and 32 respectively at the end of experimental period. Free cholesterol: The free cholesterol level of the control I was elevated 12 fold higher at week 9 than the level prior to the experiment, and then began to decrease. A significant inhibition in the increase of serum free cholesterol level was observed in AAS-H, AAS-L and CPIB groups after week 2, and in AA group after week 8. AAS-H group had the lowest level (53 % of the control I at the end of experimental period).
Triglycerides: A significant inhibition in the increase of serum triglyceride level was observed in AAS groups after week 4, in CPIB group after week 6, and in AA group after week 8. The level of AA group was 62% lower in week 10 than that of the control 1.
Phospholipids: Serum phospholipid level of the control I was elevated 7 fold over the initial value in week 10. The increase was significantly inhibited in AAS and CPIB groups after week 4, and in AA group after week 8. Changes in lipid levels of liver and aorta Table 2 shows the lipid contents in the liver and in the intima of the thoracic aorta.
The total cholesterol level in liver of the control I was approx. 2 fold higher than that of the control II. The level was significantly lower in AAS-H and CPIB groups than that in the control I. The level of triglycerides in the liver was not changed significantly in all groups.
Total cholesterol content in aorta was significantly lower in the treated groups than that in the control I. Aorta from AAS-H group contained only one fifth of the amount of cholesterol found in aorta from the control I. The level of triglycerides in aorta was sig nificantly decreased only by CPIB treatment. Table 3 is a comparison of the relative weight of organs (g/kg body weight) from the treated and the control groups. Though there was no difference in the values of heart, lung, kidney and brain between these groups, the value in spleen was significantly lower in all the treated groups compared to that in the control. I. The relative weight of liver was also significantly decreased in the three treated groups except for the AAS-L group.
Weight of various organs
Histopathological examinations
The results of histopathological examinations are shown in Table 4 . The degree of the histopathological changes was expressed 0 (no change), 1 (slight changes), 2 (milder changes) and 3 (severe changes), and the mean of the numbers in the respective group re presented the severity of the histopathological changes.
Heart: Gross appearance was normal in all specimens. In histopathological exami nations, however, intimal proliferation of arteries in the myocardium was observed in the rabbits from the all groups (Photo. 8, Table 5 The rate of intimal pathological changes in myocardial arteries was calculated as described in "materials and methods", and the results are presented in Table 5 . The development of pathological changes was significantly prevented by the high dose of AAS and CPIB. Aorta: Various sizes of atheromatous plaques were present in aorta from thoracic to iliac (Photos. 1-5). Table 6 shows the rate of the area atheromatous to normal in the intima stained with Sudan III. The rate was significantly lower in all the treated groups than that of the control I. In the rabbits from the all groups, there was a remarkable intimal thickening induced by an accumulation of foamy cells in intima and media , where various sizes of lipid droplets and doubly refractive cholesterol crystals were present. The develop ment of pathological changes in the intima and media of aorta was significantly prevented by both doses of AAS, AA and CPIB (Photos. 6, 7, Table 4 ) .
Lung: Gross appearance was normal in all specimens. Partial intimal proliferation due to accumulation of foamy cells was present in the pulmonary arteries at the rates of 8/9
in the control I, 1/8 in AAS-H group, 2/9 in AAS-L group , 5/9 in AA group and 2/8 in CPIB group (Table 4) ological changes were present in the specimens from the control 1, while the changes were just moderately mild or mild in those from the treated groups (Table 4) . Kidney: Gross appearance was normal in all specimens. No alteration was observed histopathologically in interlobar and arch of arteries. The glomerular wall contained foamy cells, which appeared in 3 specimens out of 9 rabbits from the control I and one out of 9 both from AAS-L and AA groups. No specimen from AAS-H and CPIB groups revealed foamy cells in the glomerular wall (Table 4) . Fine droplets of lipids were most abundant in specimens from the control I.
Adrenal: Swelling and roughness of the cortex cells was present in all specimens.
The degree of the changes was greater in rabbits from the control I than in those from the treated groups. Lipid staining made visible various sizes of lipid droplets and doubly refractive cholesterol crystals in the cortex cells (Table 4 ).
Brain and basilar arteries: No alteration in gross appearance and pathological changes was present in any specimen (Table 4) .
DISCUSSION
The natural occurrence of AAS, a sulfate ester of AA, has been reported in cysts of brine shrimp (10), in human urine (II), and in rat bile and tissues (12, 13) . Some investigators have suggested that this compound may function as a sulfate donor and also as a stable storage of AA (1014).
As AA is assumed to be involved in lipid metabolism, it was of interest to investigate the effect of AAS, a derivative of AA, on lipid metabolism.
Concerning ethiology of atherosclerosis, numerous theories have been proposed including theories of lipid infiltration, inflammation, and metabolic disorder, anoxia and bleeding in arteries (15) . Among them, a theory proposed by Friedman (16) has been commonly accepted, that is, an increased inflow of excessive serum lipids into arterial walls impairs filtration of lipids through lymphatic ducts at internal elastic membrane, which in turn leads to an accumulation of lipids and atheromatous lesions. Since Antischkow et al.
(17) successfully produced atheroma in cholesterol fed rabbits and this atheroma resembled human atherosclerotic lesions, possibilities of involvement of lipids in development of atherosclerosis have been extensively studied. This technique was also often employed for evaluation of antiatherosclerotic agents (18, 19) .
In this paper, the effects of AAS on hyperlipidemia and atherosclelosis with cholesterol feeding was investigated in comparison to those of AA, a parent compound and CPIB, a well-known cholesterol lowering drug. The dose of AA (150 mg/kg) was selected as an approx. molar equivalent to 300 mg/kg of AAS. The dose of CPIB (75 mg/kg) was also selected as a dose commonly used in animal experiments.
AAS prevented an increase in lipid levels of serum, liver and aorta caused by cholesterol feeding (Tables 1, 2 ). Hypolipidemic effects of AAS and CPIB were observed after week 2 of the treatment, whereas those of AA were shown after week 8 (Table 1) . Lipid levels in liver and aorta were lowest in the AAS-H group with the exception of triglycerides in aorta (Table 2 ). In addition to these changes in lipid levels, cholesterol feeding resulted in a weight increase in some organs (Table 3) , pathological changes in various organs (Table 4 ) and development of atherosclerosis in the aorta (Photos. 1-5) and in arteries of various organs (Photos. 6-9, Table 4 ). Coinciding with the hypolipidemic effects, AAS alleviated some of these changes.
Serum lipid levels, in particular the cholesterol level, is commonly assumed to be critical for atherogenesis. Our results indicate that AAS possesses inhibitory effects on the increase of lipid levels in serum and various organs, and a preventive effect on development of ather osclerosis. These results also suggest that the development of atherosclerosis was well As some authors suggested that AAS and AA are interconvertible in animal tissues (11, 14) , hypolipidemic and antiatherosclerotic effects of AAS may be elicited through the intermediary of AA. On the other hand, Verlangieri & Mumma (14) reported an increased excretion of cholesterol sulfate into feces in rats that had been given AAS by intracardial injection. Therefore, AAS may exert these effects by means of the specific mechanism for AAS.
The physiological roles of the endogenous AAS in animal tissues and the mechanism of the hypolipidemic and antiatherosclerotic effects of the exogenous AAS are now under investigation in our laboratory. 
